EyePoint EYPT

EyePoint, Inc. · Nasdaq · Laboratory Analytical Instruments

$0.38+4.83%close on Oct. 28, 2026 · volume 6.5M · Yahoo Finance

Price, last 47 sessions

$2.00$4.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $5.01 · low $0.36 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Aug. 18, 2026Karen L. Zaderej
director
Bought10,600$4.93$52,258

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 16 →
  • SCHEDULE 13GOct. 27, 2026, 5:51 p.m. ETView on SEC.gov
  • 8-KOct. 19, 2026, 9:22 a.m. ETView on SEC.gov

    Results of operations and financial condition · Costs of exit or disposal activities · Other events · Financial statements and exhibits

    AI summary, unreviewedEyePoint cuts 53% of workforce and ends wet AMD Phase 3 early after LUCIA miss, pivots to DME with ~$30 million annualized savings

  • 8-KOct. 19, 2026, 7:05 a.m. ETView on SEC.gov

    Other events · Financial statements and exhibits

    AI summary, unreviewedEyePoint's DURAVYU misses primary non-inferiority endpoint in LUCIA Phase 3 wet AMD trial, a second miss after LUGANO

  • SCHEDULE 13G/AOct. 7, 2026, 7:22 a.m. ETView on SEC.gov
  • 8-KSept. 10, 2026, 7:05 a.m. ETView on SEC.gov

    Other events · Financial statements and exhibits

  • SCHEDULE 13GSept. 8, 2026, 11:50 a.m. ETView on SEC.gov
  • 4Aug. 24, 2026, 4:10 p.m. ETView on SEC.gov
  • 4Aug. 18, 2026, 4:08 p.m. ETView on SEC.gov